Aqua Bio Technology ASA: Commercial update Moana Skincare & B Natural

24 Feb 2023 11:31 CET

24.2.2023 11:30:57 CET | Aqua Bio Technology ASA | Non-regulatory press releases

Reference is made to the stock exchange notice of ABT's acquisition of all
rights to Moana Skincare (https://newsweb.oslobors.no/message/513214) and the
following internal review of the products, packaging and documentation before
further commercializing these products. ABT has also further developed a sister
brand to Moana Skincare, B Natural, that is based on the same formulations as
Moana Skincare and which will further expand the commercial opportunities of
these products.

ABT announces today that it has successfully professionalized the female and
male products (in total 15 for each series) for Moana Skincare and B Natural and
that all products have passed the requirements for commercialization according
to the EU regulations. The tests were performed at Eurofins [
https://www.eurofins.com/about-us/], which is the world's largest in testing
food, environment, medicine and cosmetics and has 800 laboratories in more than
50 different countries.

ABT is very satisfied to have completed this process and, at the same time,
preserve the uniqueness of these products and the brand. It has been imperative
to continue using the potent extracts from plants found in New Zealand's
unspoiled nature. These products needed to be professionalized in order to
thrive on its excellence. The cornerstone of these products is a red seaweed
found in the waters around New Zealand. ABT expects B Natural to be available
for customers towards the end of Q2-2023. For Moana Skincare, the company is in
the final phase of reviewing packaging and the expectation is to have products
available during first half of 2023.

The company will be updating its websites related to this in the coming weeks
and hope consumers, investors and business partners will appreciate this as well
as follow the company and its affiliated pages on LinkedIn (
https://www.linkedin.com/company/aqua-bio-technology/), and in other social
media.

****

For further information, please contact CEO Håvard Lindstrøm mobile phone +47
941 32 288.

Aqua Bio Technology (ABT) is developing and commercializing sustainable
biotechnology for use in skincare products. ABT's cosmetics ingredients are
highly effective and they provide the cosmetics industry with natural
alternatives to traditional ingredients. ABT is also marketing and distributing
natural skincare products developed by partners towards consumers and
professional users. ABT's focus on commercialization and development of natural
ingredients and natural skincare products has been, and will continue to be, an
important part of the Company's strategy going forward. Aqua Bio Technology is
listed on the Euronext Expand market of the Oslo Stock Exchange.

DISCLOSURE REGULATION

This information is subject of the disclosure requirements pursuant to section
of 5-12 of the Norwegian Securities Trading Act.

CONTACTS

* Håvard Lindstrøm, 004794132288, hl@aquabiotech.no

ABOUT AQUA BIO TECHNOLOGY ASA

Aqua Bio Technology (ABT) is developing and commercializing sustainable
biotechnology for use in skin care products. ABT's cosmetics ingredients are
highly effective and they provide the cosmetics industry with natural
alternatives to traditional ingredients. ABT is also marketing and distributing
natural skin care products developed by partners towards consumers and
professional users. Aqua Bio Technology is listed on Euronext Expand.

ATTACHMENTS

Download announcement as PDF.pdf -
https://kommunikasjon.ntb.no/ir-files/17847556/2133/2870/Download%20announcement
%20as%20PDF.pdf

More information:
Access the news on Oslo Bors NewsWeb site

583492_en_Download announcement as PDF.pdf